Taiwan's Food and Drug Administration (FDA) on Friday issued a product warning for the weight loss drug Belviq, after American medical authorities reported on Thursday that clinical trials on the drug's active ingredient, lorcaserin, showed an increased risk of several types of cancer.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Universal NT$10,000 cash handout to be available as early as Nov. 12
10/23/2025 10:25 PM - Society
High Court rules ex-president Chen Shui-bian cannot be prosecuted
10/23/2025 10:19 PM - Business
AI demand lifts Taiwan's industrial production in September, outlook upbeat
10/23/2025 09:48 PM - Cross-Strait
MAC warns against cooperating with TAO Facebook 'bounty' posts
10/23/2025 09:30 PM - Cross-Strait
Retired Taiwanese general sentenced to 7.5 years for China plot
10/23/2025 09:23 PM